Safety of IV pulse methylprednisolone therapy during breastfeeding in patients with multiple sclerosis

BOZ, CAVİT; TERZİ, MURAT; Karahan, Serap; Sen, Sedat; Sarac, Yasemin; Mavis, Murat

doi:10.1177/1352458517717806

Safety of IV pulse methylprednisolone therapy during breastfeeding in patients with multiple sclerosis

BOZ C., TERZİ M., Karahan S. Z., Sen S., Sarac Y., Mavis M. E.

MULTIPLE SCLEROSIS JOURNAL, cilt.24, sa.9, ss.1205-1211, 2018 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 24 Sayı: 9
Basım Tarihi: 2018
Doi Numarası: 10.1177/1352458517717806
Dergi Adı: MULTIPLE SCLEROSIS JOURNAL
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1205-1211
Anahtar Kelimeler: Multiple sclerosis, postpartum relapse, lactation, breast milk, methylprednisolone, POSTPARTUM MS RELAPSES, HUMAN-MILK, FOLLOW-UP, PREGNANCY, GLUCOCORTICOIDS, CYCLOSPORINE, MANAGEMENT, EXCRETION, WOMEN
Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Background: Women with multiple sclerosis (MS) experience an increased risk of relapse in the postpartum period. High-dose methylprednisolone is the first-line treatment for acute relapses.